Lowering intraocular pressure (IOP) is the only proven therapeutic intervention for
glaucomatous optic neuropathy. Despite advances in laser and microsurgical techniques …

Glaucoma is an optical neuropathy associated to a progressive degeneration of retinal
ganglion cells with visual field loss and is the main cause of irreversible blindness in the …

Glaucoma is the leading cause of irreversible blindness worldwide. As a chronic disease,
glaucoma presents a significant burden to the individual, health‐care provider and the …

In the search for new compounds to reduce intraocular pressure (IOP), with fewer side
effects, we have found that agomelatine, a melatonin analogue, can reduce IOP being …

Клиническая офтальмология роговицы, жжение и зуд в глазах, гиперемия кожи век,
кратковременное нарушение остроты зрения; блефарит, конъюнктивит, кератит, при …

Elevated eye pressure is the main risk factor for glaucoma; intraocular pressure rises when
the ratio between aqueous humor formation (inflow) and its outflow is unbalanced. Currently …

A bstract Glaucoma is one of the leading causes of irreversible blindness in the world.
Although numerous factors have been implicated in the pathogenesis of glaucoma, the main …

Purpose: To determine the 24-h effects of brinzolamide/brimonidine tartrate 1%/0.2% fixed
combination (BBFC) on intraocular pressure (IOP), ocular perfusion pressure (OPP), blood …

Introduction: Glaucoma is a prevalent ocular disease with characteristic optic disc and visual
field changes. Globally, it is the second most common cause of visual disability, and the …

Advancements in the field and rising interest among pharmaceutical researchers have led to
the development of new molecules with enhanced therapeutic activity. Design of new drugs …